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Abstract
In our investigation of invitro antimalarial screening of medicinal herbal extracts. the n-BUOH extract from the root of Wikstroemia indica showed a potent inhibitory effect. Fractionation of the active extract led to the isolation of two biflavonoids, sikokianin B (1) and sikokianin C (2) with IC56 values 0.54 pg/ml and 0.56 gg/ml, respectively, against the chloroquine-resistant strain of Plasmodium falciparum. This is the first report of the biological activity of 1 and 2. As the structure of I has remained unsettled, we confirmed the conformation bv 1H_ and 13C_NMR.
To discover antimalarial substances from medicinal herbs, EtOAc-, n-BuOH-and Hro-soluble fractions were prepared from the initial EIOH/H2O (1 :1) extracts. These were then screened in vitro against the chloroquine-resistant I(1 strain of Plasmodium falciparum. This revealed that the n-BuOH-soluble fraction of the root of Wikstroemia indica (Linne) C. A. Meyer (Thymelaeaceae) had appreciable antimalarial inhibitory activity (Table 1) .
The n-BuOH extract was then subjected to activity-guided purification by column chromatography on silica gel, followed by medium pressure liquid chromatography (MPLC), which gave three fractions (fr.1, fr.2 and fr.3). Compounds 1 and 2 were obtained from fr.l and fr.2, respectively, in a pure form by repeated MPLC. Each purification step enhanced the antimalarial potency, with the IC56 values of 1 and 2 being determined as 0.54 prg/ml and 0.56 pg/ml (Table 1) , respectively. Compounds 1 and 2 showed almost similar activity with chloroquine, but they had one fifty-seventh activity compared with artemisinin. Table 1 Inhibitory effects of fractions and compounds from W. indico for antimalarial activity against l(1 , FCR3 and cytotoxicity against MRC-5 cells J = 9.0H2)/C-3 (6H = 3.33, dd, J = 9.0, 3.5H2), C-3lC-3" (5u = 3.23, dd,J = 3.5,3.5H2) and C-2" (5H = 5.52, d,J = 3.5H2)l C-3" positions exhibited trans, cfs and cis geometry, respectively. Further from the NOESY spectra, significant spatial conjugations between H-2lH-2"' (H-6"') were observed. The relative stereochemistry of compound 1 was confirmed as shown in Fig.1 .
Since the compound 1 was previously reported as sikokianin B
[1] of which the chirality at the C-3lC-3" position and the detailed assignment by NMR were unsettled, we assigned and confirn-red the structure by the spectral data. Analysis of the spectral data showed compound 2 to be sikokianin C [2] (Fig.1) . No previous reports have appeared for the isolation of 1 and 2 from the root of W. indicq or of them having antimalarial activity. The root of W. indica has been used for the treatment of scrofula, rheumatalgia, carbuncle, traumatic injury, etc. in China [3] but it is not used for malaria.
Compounds 1 and 2 were assayed against the drug-sensitive FCR3 P. falciparum strain, with the resulting IC50 values of 0.54 pglmL and 0.34 !g/m[ respectively. The activity of 1 and 2 against both the I(1 and FCR3 strains was similar suggesting no cross-resistance with chloroquine. Compounds 1 and 2 showed the selectivity indexes (cytotoxicity [1C56 for the MRC-5 cells]/antimalarial activity [1C56 for the I(1 strain]) with the ratios of 41J and 20.0, respectively. The results discussed above contribute to a growing list of bioactive compounds obtained from natural sources and as such may provide lead compounds for synthesis of more effective antimalarials.
Materials and Methods
Optical rotations were measured with a JASCO polarimeter at 30 C. rHand r3C-NMR spectra were determined on a Varian Unity 400 machine. Mass spectra (MS) were obtained on a JEOL MXA-AM505HA s pectrometer. The solution was concentrated to 400 mL and extracted twice successively with EtOAc (400 mL) and n-BuOH (400 mL). The EtOAc-, n-BuOH-and HrO-soluble fractions were evaporated to dryness under vacuum to give each residue of the extract (1.2 g, 1.1 g, 3.3 g), respectively. In three extracts, the antimalarial active n-BuOH extract (1.0 g) was chromatographed over a silica gel column (100 g), and was separated by gradient elution with nhexane-EtOAc which yielded after the first 1200 mL of 9: 1, 0.14 gof Fr.l (elution after 600 mL of 9 : 1 -+ 8:2), 0.45 g of Fr.2 (8:2 --> 6:4,900 mL) and 0.16gof Fr.3 (6:4 -+ 7:3, 800 mL). The active fraction Fr.3 (0.159)was subjected to MPLC on ODS octadecyl silica gel (3.S r 30 cm) eluting by gradient elution with MeOH-H2O (5 ml/min, linear gradient, 55:45 -+ 95:5, for 3 h) to yield three fractions (fr.1 :540 -620 mL,23 mg, fr.2 :650-710 mL,27 mg and fr.3:730-860 m1,90 mg). Compounds 1 (20 mg) and 2 (20 mg) were obtained from fr.1 and fr.2, respectively, by repeating the purification on MPLC. Antimalarial activity and cytotoxicity: The assays were performed as described in the previous paper [4] . Antimalarial assays were conducted using the drug-resistant I(1 strain and the drug-sensitive FCR3 strain of Plasmodiumfalciparum. Chloroquine and artemisinin were used as positive controls. Cytotoxicity was assayed against human diploid embryonic cell line MRC-5.
